Search

Search Results

• Chemotherapy-colchicine interaction in a child with Familial Mediterranean Fever and Hodgkin Lymphoma

  Karin Petra Sabine Langenberg-Ververgaert, Ronald M. Laxer, Angela S. Punnett, Lee L Dupuis, Yaron Finkelstein, Oussama Abla

  e2018019

  2018-03-01

  https://doi.org/10.4084/mjhid.2018.019

  3048

  PDF: 963

  HTML: 484

• SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival

  Stergios Intzes, Marianthi Symeonidou, Konstantinos Zagoridis, Aikaterini Pentidou, Spanoudakis Emmanouil

  e2021006

  2021-01-01

  https://doi.org/10.4084/mjhid.2021.006

  2371

  PDF: 944

  HTML: 389

• Nodular lymphocyte-predominant Hodgkin lymphoma in a patient with Familial Mediterranean Fever

  Marina Belia, Asimina Papanikolaou, Panagiotis Skendros, Theodoros Vassilakopoulos

  e2022059

  2022-06-29

  https://doi.org/10.4084/MJHID.2022.059

  1112

  PDF: 598

  HTML: 331

• BACTERIAL INFECTIONS FOLLOWING SPLENECTOMY FOR MALIGNANT AND NONMALIGNANT HEMATOLOGIC DISEASES

  Giuseppe Leone, Eligio Pizzigallo

  e2015057

  2015-10-12

  https://doi.org/10.4084/mjhid.2015.057

  5285

  PDF: 2152

  HTML: 8845

• Primary pulmonary Hodgkin Lymphoma simulating a mediastinal tumour: an uncommon occurrence.

  Stefano Fratoni, Pasquale Niscola, Elisabetta Abruzzese, Malgorzata Monika Trawinska, Edoardo Mercadante, Andrea Casullo, Paolo de Fabritiis, Alessio Perrotti, Giuseppe Santeusanio

  e2013013

  2013-02-16

  https://doi.org/10.4084/mjhid.2013.013

  1444

  PDF: 776

  HTML: 2007

• Sarcoid-like Reactions in Hodgkin Lymphoma Treated with Pembrolizumab: a Case Report

  Pier Luigi Zinzani, Flavia Salvatore, Beatrice Casadei, Camilla Mazzoni, Marianna Gentilini, Giulia Gabrielli, Lisa Argnani

  e2026052

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.052

  429

  PDF: 344

  HTML: 57

• IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy

  İbrahim Halil Açar, Sebnem Izmir Güner , Muzeyyen Aslaner Ak, Mesut Gocer, Erman Ozturk , Figen Atalay, Gulden Sincan , Aysun Senturk Yikilmaz, Omer Ekinci, Idris Ince, Emine Gulturk , Nazli Demir, Ali Dogan, Yildiz Ipek, Birol Guvenc

  e2022074

  2022-10-29

  https://doi.org/10.4084/MJHID.2022.074

  2159

  PDF: 902

  HTML: 273

• Response to ibrutinib of a refractory IgA lymphoplasmacytic lymphoma carrying the MYD88 L265P gene mutation

  Francesca Maria Quaglia, Gian Matteo Rigolin, Elena Saccenti, Massimo Negrini, Eleonora Volta, Melissa Dabusti, Maria Ciccone, Antonio Urso, Michele Laudisi, Antonio Cuneo

  e2019057

  2019-08-29

  https://doi.org/10.4084/mjhid.2019.057

  1747

  PDF: 1067

  HTML: 319

• A rare immune-related mesenteric and retroperitoneal serositis in a multirefractory Hodgkin lymphoma patient successfully treated with chylolymphostatic surgery

  Matteo D'Addona, Luca Pezzullo, Corradino Campisi, Corrado Cesare Campisi, Valentina Giudice, Vincenzo Ciccone, Roberto Guariglia, Bianca Serio, Carmine Selleri

  e2023063

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.063

  828

  PDF: 498

  HTML: 177

• Prognostic Impact Of Baseline Immunologic Profile In Aggressive B-cell Non-Hodgkin’s Lymphomas

  Safaa M. Ramadan

  e2021018

  2021-02-26

  https://doi.org/10.4084/mjhid.2021.018

  1275

  PDF: 477

  HTML: 285

• T-cell Large Granular Lymphocytic Leukemia Manifesting in Patients with HIV-1 Infection: Cases Series and Review of the Literature

  Ashley M Rose, Leidy Isenalumhe, Magali VanDenBergh, Lubomir Sokol

  e2018036

  2018-06-21

  https://doi.org/10.4084/mjhid.2018.036

  2776

  PDF: 1042

  HTML: 433

• TOLL-LIKE RECEPTORS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Marta Muzio, Eleonora Fonte, Federico Caligaris-Cappio

  e2012055

  2012-08-09

  https://doi.org/10.4084/mjhid.2012.055

  2765

  PDF: 960

  HTML: 17628

  Fig1 Caligaris: 249

  Fig.2 Caliga: 283

• INFLUENZA AND PNEUMOCOCCAL VACCINATION IN HEMATOLOGICAL MALIGNANCIES: A SYSTEMATIC REVIEW OF EFFICACY, EFFECTIVENESS AND SAFETY

  Giuseppe La Torre

  e2016044

  2016-09-01

  https://doi.org/10.4084/mjhid.2016.044

  4898

  PDF: 1602

  HTML: 3487

• PERIPHERAL NERVOUS SYSTEM INVOLVEMENT IN LYMPHOPROLIFERATIVE DISORDERS

  Mario Sabatelli, Luca Laurenti, Marco Luigetti

  e2018057

  2018-09-01

  https://doi.org/10.4084/mjhid.2018.057

  1923

  PDF: 955

  HTML: 485

  Fig1: 293

  Fig.2: 323

  Fig. 3: 253

  Fig. 5: 274

  Fig. 4: 284

• CROCIN PROMOTES APOPTOSIS IN HUMAN EBV-TRANSFORMED B-LYMPHOCYTE VIA INTRINSIC PATHWAY CROCIN PROMOTES APOPTOSIS IN EBV-TRANSFORMED LCL

  Abdolreza Sotoodeh Jahromi, Mohammad Kargar, Farshid Kafilzadeh, Marzieh Jamalidoust, Maliheh Moradzadeh

  e2021049

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.049

  1482

  PDF: 591

  HTML: 312

• EVOLVING DISEASE SPECTRUM AND CHARACTERISTICS OF PEOPLE WITH HIV IN EASTERN CHINA: A 12-YEAR STUDY

  Ye Xiong, Bohao Dai, Dairong Xiang, Jean-Pierre Routy, Biao Zhu

  e2025077

  2025-10-31

  https://doi.org/10.4084/MJHID.2025.077

  776

  PDF: 342

  Html: 178

• Pathogen distribution, antimicrobial resistance, and mortality in febrile neutropenia among adults with hematological malignancies: a single-center cohort study

  Rukiyye Bulut, İbrahim Erayman, Ceren Eryılmaz Yaman, Bahar Kandemir, Pınar Belviranlı Keskin, Esma Kepenek Kurt, Özcan Çeneli

  e2026082

  2026-10-31

  https://doi.org/10.4084/MJHID.2026.082

  135

  PDF: 57

  Suppl. Files: 16

  Html: 41

  Html Suppl. Files: 8

• Post-therapy B regulatory cells might early predict relapse in Hodgkin lymphoma

  Valentina Giudice, Luca Pezzullo, Giuseppe Ciancia, Matteo D'Addona, Francesca D'Alto, Marisa Gorrese, Bianca Cuffa, Carmine Selleri

  e2022042

  2022-04-28

  https://doi.org/10.4084/MJHID.2022.042

  1046

  PDF: 512

  HTML: 229

• INVASIVE FUNGAL INFECTIONS IN PATIENTS WITH CHRONIC LYMPHOPROLIFERATIVE DISORDERS IN THE ERA OF TARGET DRUGS

  Livio Pagano, Davide Facchinelli, Dr.

  e2018063

  2018-10-27

  https://doi.org/10.4084/mjhid.2018.063

  2225

  PDF: 1202

  HTML: 371

• EFFICACY AND SAFETY OF CLADRIBINE: SUBCUTANEOUS VERSUS INTRAVENOUS ADMINISTRATION IN HAIRY CELL LEUKEMIA PATIENTS

  Ola Khorshid, Safaa M. Ramadan

  e2015058

  2015-10-16

  https://doi.org/10.4084/mjhid.2015.058

  2254

  PDF: 1153

  HTML: 1272

• Counting the Cost: How Anticipating Financial Burden Affects Post-Traumatic Stress Symptoms in Patients Newly Diagnosed with Leukemia and Lymphoma

  Fabio Guolo, Paola Del Sette, Francesca Riccardi, Paola Minetto, Andrea Todiere, Filippo Ballerini, Carola Riva, Michele Cea, Roberto Massimo Lemoli, Elena Sarcletti

  e2026029

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.029

  569

  PDF: 482

  HTML: 115

• Pathogenetic mechanism of macular edema during a treatment with ibrutinib: a case presentation.

  Cristina Mauro, Livio Pupo, Lucia Cardillo, Fabiana Esposito, Elisa Buzzatti, Marco Lombardo, Massimo Cesareo, Adriano Venditti, Massimiliano Postorino, Maria Ilaria Del Principe

  e2026009

  2026-01-01

  https://doi.org/10.4084/MJHID.2026.009

  728

  PDF: 550

  Html: 327

• THERAPY-RELATED MYELOID NEOPLASMS IN CHRONIC LYMPHOCYTIC LEUKEMIA AND WALDENSTROM MICROGLOBULINEMIA

  Francesca Ricci, Alessandra Tedeschi, Marco Montillo, Enrica Morra

  e2011031

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.031

  2497

  PDF: 1057

  HTML: 2517

• Editorial : INTRODUCING MEDITERRANEAN JOURNAL OF HEMATOLOGY AND INFECTIOUS DISEASES

  Giuseppe Leone, Luigi Maria Larocca, Eligio Pizzigallo

  e2009001

  2009-06-22

  3605

  PDF: 644

  HTML: 745

• EBV CHRONIC INFECTIONS

  Eligio Pizzigallo, Delia Racciatti, Valeria Gorgoretti

  e2010022

  2010-08-09

  https://doi.org/10.4084/mjhid.2010.022

  3759

  PDF: 1744

  HTML: 8014

• THERAPY-RELATED MYELOID MALIGNANCIES IN MYELOMA

  Xenofon Papanikolaou, Bart Barlogie, Saad Usmani

  e2011047

  2011-10-24

  https://doi.org/10.4084/mjhid.2011.047

  2674

  PDF: 886

  HTML: 1767

• MANAGEMENT OF LATENT TUBERCULOSIS INFECTION BASED ON T-SPOT.TB ASSAY IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

  Emrah Kiliacaslan, Kadir Canoglu

  e2023003

  2022-12-31

  https://doi.org/10.4084/MJHID.2023.003

  1909

  PDF: 1223

  HTML: 561

• ELOTUZUMAB FOR THE TREATMENT OF RELAPSED OR REFRACTORY MULTIPLE MYELOMA, WITH SPECIAL REFERENCE TO ITS MODES OF ACTION AND SLAMF7 SIGNALING

  Masafumi Taniwaki, Mihoko Yoshida, Yosuke Matsumoto, Kazuho Shimura, Junya Kuroda, Hiroto Kaneko

  e2018014

  2018-02-15

  https://doi.org/10.4084/mjhid.2018.014

  5540

  PDF: 2070

  HTML: 2389

• APPLICATION OF NEW DRUGS IN CHRONIC LYMPHOCYTIC LEUKEMIA

  Tadeusz Robak

  e2010011

  2010-05-07

  https://doi.org/10.4084/mjhid.2010.011

  1775

  PDF: 717

  HTML: 2457

• THERAPY-RELATED MYELOID NEOPLASMS: PREDISPOSITION AND CLONAL EVOLUTION T-AML predisposition

  Emiliano Fabiani, Dr. Falconi, Dr. Cristiano, Dr. Hajrullaj, Dr. Falconi, Prof. Leone, Prof. Voso

  e2023064

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.064

  1661

  PDF: 1043

  HTML: 275

• MOLECULAR CHARACTERIZATION OF EPSTEIN - BARR VIRUS BASED ON EBNA3C PROTEIN AMONG HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS IN JORDAN

  Rabaa Athamneh, Hiba Swaity, Waleed Almomani, Hayyan. Taweil , Assia Benbraiek, Anas Khalifeh

  e2025032

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.032

  972

  PDF: 952

  HTML: 144

• Cytokine release syndrome after haploidentical transplantation is associated with improved survival without increasing transplant-related mortality

  Daniele Avenoso, Natalia Difrancesco, Enrico Morello, Gabriele Magliano, Mirko Farina, Vera Radici, Simone Bernardi, Alessandro Leoni, Federica Re, Shreyas Hanmantgad, Domenico Russo, Michele Malagola

  e2026059

  2026-06-30

  https://doi.org/10.4084/MJHID.2026.059

  279

  PDF: 220

  HTML: 242

• Very late onset Post-Transplantation Lymphoproliferative Disorder (PTLD) after haematopoietic stem cell transplant (HCT) – A Clinical Case

  Sharon Lionel, Liron Barnea Slonim, Guy Hannah, Victoria Potter, Daniele Avenoso

  e2024048

  2024-04-30

  https://doi.org/10.4084/MJHID.2024.048

  1208

  PDF: 1072

  HTML: 176

• Impact of Sars-CoV-2 prophylaxis with tixagevimab-cilgavimab in high-risk patients with B-cell malignancies: a single-center retrospective study.

  Giovanni Manfredi Assanto ,, Matteo Totaro , Poggiali Rebecca, Delli Paoli Adele, Annechini Giorgia, D’Elia Gianna Maria, Aji Francesco, Petrucci Luigi, Fazio Francesca, Del Giudice Ilaria, Martelli Maurizio, Micozzi Alessandra, Giuseppe Gentile

  e2023061

  2023-10-30

  https://doi.org/10.4084/MJHID.2023.061

  1014

  PDF: 539

  HTML: 222

• THE START-UP OF THE FIRST HEMATOPOIETIC STEM CELL TRANSPLANTATION CENTER IN THE IRAQI KURDISTAN: A CAPACITY-BUILDING COOPERATIVE PROJECT BY THE HIWA CANCER HOSPITAL, SULAYMANIYAH, AND THE ITALIAN AGENCY FOR DEVELOPMENT COOPERATION

  Ignazio Majolino

  e2017031

  2017-04-15

  https://doi.org/10.4084/mjhid.2017.031

  2603

  PDF: 1102

  HTML: 2146

• JC Virus leuko-encephalopathy in reduced intensity conditioning cord blood transplant recipient.

  jean elcheikh

  e2012043

  2012-06-20

  https://doi.org/10.4084/mjhid.2012.043

  1222

  PDF: 916

  HTML: 10970

• ANORECTAL COMPLICATIONS DURING NEUTROPENIC PERIOD IN PATIENTS WITH HEMATOLOGIC DISEASES

  Soner Solmaz

  e2016019

  2016-03-01

  https://doi.org/10.4084/mjhid.2016.019

  3184

  PDF: 1074

  HTML: 1605

• A case of multiple myeloma in a patient in treatment for chronic lymphocytic leukemia

  Mario Biglietto, Ugo Coppetelli, Luciano Fiori, Martina Gherardini, Raffaele Maglione, Alessandro Pulsoni, Azzurra Anna Romeo

  e2025033

  2025-04-30

  https://doi.org/10.4084/MJHID.2025.033

  1001

  PDF: 769

  HTML: 219

• HIV-ASSOCIATED VENOUS THROMBOEMBOLISM

  Michele Bibas, Gianluigi Biava, Andrea Antinori

  e2011030

  2011-07-08

  https://doi.org/10.4084/mjhid.2011.030

  4728

  PDF: 1602

  HTML: 8563

• COVID-19 IN CHILDREN AND ADOLESCENT: CHARACTERISTICS AND SPECIFICITIES IN IMMUNOCOMPETENT AND ONCOHEMATOLOGICAL PATIENTS COVID-19 IN CHILDREN AND ADOLESCENT.

  Federico Mercolini, Simone Cesaro

  e2022009

  2022-01-01

  https://doi.org/10.4084/MJHID.2022.009

  2887

  PDF: 1034

  HTML: 615

• Immune Biomarker Signature in the Diagnostic Workup of Fever Without Source: A Pilot Study

  Angela Maria Di Francesco, Giuliana Pasciuto, Laura Gerardino, Ludovico Luca Sicignano, Elena Verrecchia, Andrea Urbani, Donato Rigante, Raffaele Manna

  e2026030

  2026-02-28

  https://doi.org/10.4084/MJHID.2026.030

  634

  PDF: 564

  HTML: 202

• MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS

  Mrinalini kotru, Deepti Mutereja, Abhishek Purohit, Seema Tyagi, Manoranjan Mahapatra, Renu Saxena, Hara Prasad Pati

  e2016049

  2016-10-17

  https://doi.org/10.4084/mjhid.2016.049

  3454

  PDF: 806

  HTML: 777

  Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 248

  Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 256

  Table : Distribution of the sites of bleeding and their causes: 229

• COVID-19 post hematopoietic cell transplant, a report of 11 cases from a single center.

  Afadil Adam

  e2020070

  2020-08-29

  https://doi.org/10.4084/mjhid.2020.070

  1988

  PDF: 1221

  HTML: 424

• INVASIVE CANDIDA INFECTIONS IN PATIENTS WITH HAEMATOLOGICAL MALIGNANCIES AND HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS: CURRENT EPIDEMIOLOGY AND THERAPEUTIC OPTIONS.

  Corrado Girmenia, Erica Finolezzi, Vincenzo Federico

  e2011013

  2011-03-14

  https://doi.org/10.4084/mjhid.2011.013

  2582

  PDF: 1079

  HTML: 1881

• LYON-UNIVERSITY HOSPITAL EXPERIENCE WITH GEMTUZUMAB OZOGAMICIN THERAPY IN ACUTE MYELOID LEUKEMIA: A ‘REAL-LIFE’ STUDY Gemtuzumab ozogamicin in AML

  Xavier Thomas, Marica Laurino, sandrine loron, marie-virginie larcher, gaëlle fossard, mohamed elhamri, alexandre deloire, marie balsat, fiorenza barraco, hélène labussière, sophie ducastelle, myriam renault, eric wattel, maël heiblig, gilles salles

  e2020020

  2020-04-27

  https://doi.org/10.4084/mjhid.2020.020

  2055

  PDF: 1269

  HTML: 357

• UPDATE ON THE ROLE OF AUTOLOGOUS HEMATOPOIETIC STEM CELL TRANSPLANTATION IN MULTIPLE MYELOMA

  Patrizia Tosi, Manuela Imola, Mianulli Anna Maria, Simona Tomassetti, Anna Merli, Annalia Molinari, Serena Mangianti, Marina Ratta, Alessandro Isidori, Giuseppe Visani

  e2012069

  2012-11-05

  https://doi.org/10.4084/mjhid.2012.069

  2721

  PDF: 814

  HTML: 1660

• Acute fulminant Clostridium-Perfrigens sepsis with massive intravascular hemolysis in a young woman with sickle cell disease. Case presentation and review of the literature

  Lorenza Torti, Mauro Polzoni, Nicolina Ardu, Laura Maffei, Beatrice Basso, Maria Ilaria Del Principe

  e2026080

  2026-10-31

  https://doi.org/10.4084/MJHID.2026.080

  79

  PDF: 40

  Html: 12

• Immune thrombocytopenic purpura cases following COVID-19 vaccination.

  Annalisa Condorelli, Uros Markovic, Roberta Sciortino, Mary Ann Di Giorgio, Daniela Nicolosi, Gaetano Giuffrida

  e2021047

  2021-06-28

  https://doi.org/10.4084/MJHID.2021.047

  1232

  PDF: 510

  HTML: 371

• WHO HAS THERAPY-RELATED AML?

  Robert Gale, John M. Bennett, F. Owen Hoffman

  e2017025

  2017-03-01

  https://doi.org/10.4084/mjhid.2017.025

  3388

  PDF: 4408

  HTML: 890

• DEVELOPMENT OF AN IMPROVED EPSTEIN-BARR VIRUS (EBV) NEUTRALIZING ANTIBODY ASSAY TO FACILITATE DEVELOPMENT OF A PROPHYLACTIC GP350-SUBUNIT EBV VACCINE

  Hui Liu, Lorraine Gemmell, Rui Lin, Fengrong Zuo, Henry H. Balfour, Jr., Jennifer C. Woo, Gregory M. Hayes

  e2020016

  2020-02-26

  https://doi.org/10.4084/mjhid.2020.016

  2103

  PDF: 1180

  HTML: 457